Vaginal Discharge
12
1
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 29/100
8.3%
1 terminated out of 12 trials
85.7%
-0.9% vs benchmark
33%
4 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (12)
Vaginal and Oral Microbiome Crosstalk
In-Clinic Assessment of Vaginal Mucosal Safety Following Repetitive Use of the Livi Device
Point-of-care Tests for Vaginal Discharge in Nepal
HPV Typing Between Self- and Physician-sampled
Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters
Efficacy and Safety of the Application of Local Anaesthetic in Spray to Repair of 1st- 2nd Perineal Lacerations
Postmenopausal Pessary Users: Estrogen Versus Trimosan
Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort
Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue
Validity of Patient-Collected Wet Mounts
Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.
Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal Discharge